Yangyang Xu, Yan Wang, Fuyi Qin, Ling Yu, Weihao Li, Xu You, Li Guo, Yilin Liu, Yong Zeng
{"title":"Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia.","authors":"Yangyang Xu, Yan Wang, Fuyi Qin, Ling Yu, Weihao Li, Xu You, Li Guo, Yilin Liu, Yong Zeng","doi":"10.2147/NDT.S600571","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Schizophrenia lacks objective biomarkers, and its complex aetiology demands epigenetic insight. Given the regulatory roles of long non-coding RNAs (lncRNAs) in the nervous system and brain-relevant signals in peripheral exosomes, we evaluated lncRNA expression in patient blood cells and plasma exosomes, assessed their diagnostic value, and explored potential functions and mechanisms.</p><p><strong>Methods: </strong>Differentially expressed lncRNAs in schizophrenia-related exosomes were identified from GEO (GSE228881), and 15 candidates were selected for validation. In a clinical cohort, RT-qPCR assessed their expression in peripheral blood cells and plasma exosomes. Diagnostic accuracy was evaluated by ROC analysis. Top dysregulated lncRNAs underwent bioinformatic analyses: subcellular localization, evolutionary conservation, ceRNA network construction, and GO/KEGG enrichment.</p><p><strong>Results: </strong>ITGA9-AS1 and WNT5A-AS1 were significantly upregulated in both peripheral blood cells and plasma exosomes from patients. Both showed favorable diagnostic potential, with AUC values of 0.8422 and 0.8073, respectively, in peripheral blood; their combination yielded an AUC of 0.9180. Bioinformatics analysis revealed that ITGA9-AS1 primarily localizes to the cytoplasm, whereas WNT5A-AS1 is enriched in exosomes, with both exhibiting high evolutionary conservation. Functional predictions suggest ITGA9-AS1 may regulate neuroplasticity-related pathways such as \"long-term potentiation\" and \"cAMP signaling pathway\" via a ceRNA mechanism. WNT5A-AS1 may mediate intercellular communication through exosomes, influencing developmental and metabolic pathways, including the \"Notch signaling pathway\" and \"cysteine and methionine metabolism\".</p><p><strong>Conclusion: </strong>Our findings suggest that ITGA9-AS1 and WNT5A-AS1 are highly promising biomarker candidates for schizophrenia. They may be involved in the disease process through distinct mechanisms (intracellular regulation and intercellular communication), thus providing a new theoretical framework and suggesting potential therapeutic targets.</p>","PeriodicalId":19378,"journal":{"name":"Neuropsychiatric Disease and Treatment","volume":"22 ","pages":"600571"},"PeriodicalIF":3.2000,"publicationDate":"2026-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13281893/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychiatric Disease and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NDT.S600571","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Schizophrenia lacks objective biomarkers, and its complex aetiology demands epigenetic insight. Given the regulatory roles of long non-coding RNAs (lncRNAs) in the nervous system and brain-relevant signals in peripheral exosomes, we evaluated lncRNA expression in patient blood cells and plasma exosomes, assessed their diagnostic value, and explored potential functions and mechanisms.
Methods: Differentially expressed lncRNAs in schizophrenia-related exosomes were identified from GEO (GSE228881), and 15 candidates were selected for validation. In a clinical cohort, RT-qPCR assessed their expression in peripheral blood cells and plasma exosomes. Diagnostic accuracy was evaluated by ROC analysis. Top dysregulated lncRNAs underwent bioinformatic analyses: subcellular localization, evolutionary conservation, ceRNA network construction, and GO/KEGG enrichment.
Results: ITGA9-AS1 and WNT5A-AS1 were significantly upregulated in both peripheral blood cells and plasma exosomes from patients. Both showed favorable diagnostic potential, with AUC values of 0.8422 and 0.8073, respectively, in peripheral blood; their combination yielded an AUC of 0.9180. Bioinformatics analysis revealed that ITGA9-AS1 primarily localizes to the cytoplasm, whereas WNT5A-AS1 is enriched in exosomes, with both exhibiting high evolutionary conservation. Functional predictions suggest ITGA9-AS1 may regulate neuroplasticity-related pathways such as "long-term potentiation" and "cAMP signaling pathway" via a ceRNA mechanism. WNT5A-AS1 may mediate intercellular communication through exosomes, influencing developmental and metabolic pathways, including the "Notch signaling pathway" and "cysteine and methionine metabolism".
Conclusion: Our findings suggest that ITGA9-AS1 and WNT5A-AS1 are highly promising biomarker candidates for schizophrenia. They may be involved in the disease process through distinct mechanisms (intracellular regulation and intercellular communication), thus providing a new theoretical framework and suggesting potential therapeutic targets.
期刊介绍:
An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.